ABSTRACT
OBJECTIVE: To investigate the effects of octreotide on apoptosis of and Fas/FasL gene expression in human hepatoma cell mechanism of the suppression effect of liver cancer with e in order to offer the experimental foundation for clinic treatment. METHODS: Hyman hematoma cells of the line SMMC-7721 were cultured and divided into two groups: octreotide group, co-cultured with octreotide 4,7, and 10 microg/ml respectively for 24 h, 48 h, or 72 h, and control group. TUNEL was used to detect the apoptosis of the cells. Flow cytometry was used with terminal deoxynucleotidyl transferase mediated dUTP nick end labeling (TUNEL) technique to detect the apoptosis of the cells. FC was used with direct labeling of monoclonal antibody (CD95/CD178) to detect the expression of Fas and FasL, and the Fas/FasL ratio. RESULTS: Octreotide increased the apoptotic rate of the cells dose- and time-dependently (all P < 0.05). Octreotide increased the Fas expression rate, FasL expression rate, and Fas/FasL ratio dose- and time-dependently (all P < 0.05). CONCLUSION: Octreotide induces the apoptosis of human hepatoma cells, possibly by the mechanism of facilitating the Fas/FasL gene expression.
Subject(s)
Apoptosis/drug effects , Fas Ligand Protein/biosynthesis , Octreotide/pharmacology , fas Receptor/biosynthesis , Antineoplastic Agents, Hormonal/pharmacology , Carcinoma, Hepatocellular/metabolism , Carcinoma, Hepatocellular/pathology , Cell Line, Tumor , Dose-Response Relationship, Drug , Flow Cytometry , Humans , In Situ Nick-End Labeling , Liver Neoplasms/metabolism , Liver Neoplasms/pathology , Time FactorsABSTRACT
OBJECTIVE: To explore the prognostic factors in patients with gastrointestinal stromal tumors of the small intestine. METHODS: Tumor slides stained with hematoxylin and eosin from these patients were reviewed. Two histomorphologically representative areas were identified and arrayed on a tissue microarray. Immunohistochemistry staining were performed using antibodies to detect the expression of c-kit protein (CD117), CD34, smooth muscle actin, desmin, S-100, Ki-67, P53 and bcl-2 protein. The relationship between clinicopathologic features and prognosis was analyzed by univariate analysis. RESULTS: The 1-, 3-, 5-year survival rate of 58 such patients were 98.3%, 69.7%, and 50.9% respectively. The prognosis was related with tumor size and gender by univariate analysis (P< 0.05). CONCLUSION: More attention should be paid to the male patients with small intestine stromal tumors,especially those with tumors size> 5 cm, because those tumors are more likely to metastasize than smaller tumors (< or = 5 cm).
